Depressive symptoms and risk of stroke: The Framingham study

Stroke

Volumn 38, Issue 1, 2007, Pages 16-21

  Salaycik, Kimberly J ^a   Kelly Hayes, Margaret ^a   Beiser, Alexa ^a,b   Nguyen, Anh Hoa ^b   Brady, Stephen M ^a   Kase, Carlos S ^a   Wolf, Philip A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Depressive symptoms; Risk factors; Stroke; Transient ischemic attack

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL FEATURE; COMMUNITY CARE; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION MODEL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ANTIDEPRESSIVE AGENTS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DEPRESSIVE DISORDER; EARLY DIAGNOSIS; EDUCATIONAL STATUS; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING;

EID: 33845938439     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000251695.39877.ca     Document Type: Article

References (41)

1. Carota A, Bogoussalavsky J. Poststroke depression. Adv Neurol. 2003;92:435-445.
2. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients: a 3-year longitudinal study. Stroke. 1993;24:976-982.
3. Kotila M, Numminen H, Waltimo O, Kaste M. Depression after stroke: results of the FINNSTROKE study. Stroke. 1998;29:368-372.
4. Gainotti G, Antonucci G, Marra C, Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry. 2001;7:258-261.
5. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36:1330-1340.
6. Krishnan KR. Depression as a contributing factor in cerebrovascular disease. Am Heart J. 2000;140(suppl):70-76.
7. Ohira T, Iso H, Satoh S, Sankai T, Tanigawa T, Ogawa Y, Imano H, Sato S, Kitamura A, Shimamoto. Prospective study of depressive symptoms and risk of stroke among Japanese. Stroke. 2001;32:903-908.
8. Ariyo AA, Haan M, Tangen CM, Rutledge JC, Cushman M, Dobs A, Furberg CD. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans: Cardiovascular Health Study Collaborative Research Group. Circulation. 2000;102:1773-1779.
9. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med. 1998;158:1422-1426.
10. Wulsin LR, Evans JC, Vasan RS, Murabito JM, Kelly-Hayes M, Benjamin EJ. Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study. Psychosom Med. 2005;67:697-702.
11. Carney RM, Freedland KE, Jaffe AS. Depression as a risk factor for coronary heart disease mortality. Arch Gen Psychiatry. 2001;58:229-230.
12. Jorm AF. The epidemiology of depressive status in the elderly: implications for recognition, intervention, and prevention. Soc Psychiatry Psychiatr Epidemiol. 1995;30:53-59.
13. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006;37:345-350.
14. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-281.
15. D'Agostino RB, Kannel WB. Epidemiological background and design: The Framingham study. Proceedings of the American Statistical Association Sesquicentennial Invited Paper Sessions. Alexandria, Va: American Statistical Association; 1989:707-718.
16. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
17. Beekman AT, Deeg DJ, Van Limbeek J, Braam AW, De Vries MZ, Van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psych Med. 1997;27:231-235.
18. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
19. Wolf PA, D'Agostino RB, O'Neal MA, Sytkowski P, Kase CS, Belanger AJ, Kannel WB. Secular trends in stroke incidence and mortality: the Framingham Study. Stroke. 1992;23:1551-1555.
20. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312-318.
21. SAS/STAT: SAS/STAT Software: Changes and Enhancements. Cary, NC: SAS Institute Inc; 1996.
22. Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med. 2000;62:463-471.
23. Larson SL, Owens PL, Ford D, Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke. 2001;32:1979-1983.
24. Gump BB, Matthews KA, Eberly LE, Chang YF, MRFIT Research Group. Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial. Stroke. 2005;36:98-102.
25. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke. 1998;29:1341-1346.
26. Everson SA, Roberts RE, Goldberg DE, Kaplan GA. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 1998;158:1133-1138.
27. Colantonio A, Kasi SV, Ostfeld AM. Depressive symptoms and other psychosocial factors as predictors of stroke in the elderly. Am J Epidemiol. 1992;136:884-894.
28. Wassertheil-Smoller S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R Jr, Kostis J, Pressel S, Schron E. Change in depression as a precursor of cardiovascular events: SHEP Cooperative Research Group (Systolic Hypertension in the elderly). Arch Intern Med. 1996;156:553-561.
29. May M, McCarron P, Stansfeld S, Ben-Shlomo Y, Gallacher J, Yarnell J, Davey Smith G, Elwood P, Ebrahim S. Does psychological distress predict the risk of ischemic stroke and transient ischemic attack? the Caerphilly Study. Stroke. 2002;33:7-12.
30. Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, Hallas J, Garcia Rodriguez LA, Christensen K, Gaist D. Selective serotonin reuptake inhibitors and the risk of stroke: a population based case-control study. Stroke. 2002;33:1465-1473.
31. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001;104:1894-1898.
32. de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 1999;319:1106-1109.
33. van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ. 2001;323:655-658.
34. Kendler KS, Gatz M, Gardner CO, Pedersen NL. A Swedish national twin study of lifetime major depression. Am J Psychiatry. 2006;163:109-114.
35. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, Newman A, Hirsch C, Tracy RP. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol. 2002;89:419-424.
36. Folsom AR, Qamhieh HT, Flack JM, Hilner JE, Liu K, Howard BV, Tracy RP. Plasma fibrinogen: levels and correlates in young adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol. 1993;138:1023-1036.
37. Markovitz JH, Shuster JL, Chitwood WS, May RS, Tolbert LC. Platelet activation in depression and effects of sertraline treatment: an open-label study. Am J Psychiatry. 2000;157:1006-1008.
38. Lederbogen F, Gilles M, Maras A, Hamann B, Colla M, Heuser I, Deuschle M. Increased platelet aggregability in major depression? Psychiatry Res. 2001;102:255-261.
39. Veith RC, Barnes RF, Villacres RC, Murburg MM, Raskind MA, Borson S. Plasma catecholamines and norepinephrine kinetics in depression and panic disorder; in: Belmaker R, ed. Catecholamines: Clinical Aspects. New York: Alan Liss Inc; 1988:197-202.
40. Ladwig KH, Marten-Mittag B, Lowel H, Doring A, Koenig W, MONICA-KORA Augsburg Cohort Study 1984-1998. C-reactive protein, depressed mood and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Eur Heart J. 2005;26:2537-2542.
41. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P; PRIME Study Group. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2005;111:2299-2305.